Physician profile
Keith J Alexander
NPI 1427152800
$1,784.63
in general payments reported to CMS, 2019-2025
8 companies · $55.87 in 2025
The $55.87 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $146 · 2021: $417 · 2022: $100 · 2023: $303 · 2024: $304 · 2025: $55.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608 · Education: $54.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.95 |
| Education | $54.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $990.93 | 2019-2023 | Audion Et Dilation System |
| Regeneron Healthcare Solutions, INC. | $350.24 | 2022-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $171.05 | 2019-2021 | |
| Inspire Medical Systems, INC. | $128.40 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $54.95 | 2024 | |
| Novartis Pharmaceuticals Corporation | $36.54 | 2025 | |
| Genzyme Corporation | $28.73 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $23.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.